Episode 34: The Vaccine Edition

David Engelthaler

David Engelthaler Ph.D.

Professor and Director
Pathogen and Microbiome Division

View Profile

It took under a year to develop, test and begin to deploy vaccines against COVID-19. And despite a few hiccups upon arrival, the rollout is underway... and that's great news for a world that's nearing 100 million cases and over 2 million deaths.
  Joining TGen Talks to discuss his take on COVID-19 vaccines is Dr. David Engelthaler, Director of TGen North, the Pathogen and Microbiome Division of TGen located in Flagstaff, Arizona.
  Dr. Engelthaler discusses the vaccine's available today, those that are currently in the development pipeline and why getting vaccinated is important. He also tackles the known side-effects, the speed at which the vaccines were developed, and the recent variant strains that were discovered in the UK, South Africa and elsewhere, and which of these are already being seen in the US. 
  All that and more on this month's edition of TGen Talks.